Mumbai-based startup Rethink Bio gets selected
US-based Illumina, Inc. has invested in Mumbai-based startup Rethink Bio Private Limited, which is among the seven new genomics companies to join the fourth global funding cycle of Illumina Accelerator San Francisco Bay Area and Cambridge, UK.
The global company creation engine is focused on partnering with entrepreneurs to build breakthrough genomics startups and its next global funding cycle application deadline is April 1, 2022.
Rethink Bio is a synthetic biology company that is focused on harnessing the potential of microalgae to develop sustainable food solutions to benefit the planet and people.
During two, six-month funding cycles per year, Illumina Accelerator provides the selected startups with access to seed investment, access to Illumina sequencing systems and reagents, as well as business guidance, genomics expertise, and fully operational lab space adjacent to Illumina’s campuses in Cambridge, UK or the San Francisco Bay Area.